Experimental Clinical Physics:

Background
Anita Werensteijn-Honingh worked as a medical PhD student at the department of Radiotherapy, UMC Utrecht. She has completed a bachelor in Biomedical Sciences with a minor in Physics at Utrecht University. After that she completed the Selective Utrecht Medical Master with a Technical Track (offered in collaboration with the TU Eindhoven). From 2017 untill 2021 she did a PhD project about MR-guided stereotactic body radiotherapy (SBRT) for lymph node oligometastases. The OLYMPOS cohort study was launched to investigate both technical and clinical aspects of (MR-guided) SBRT treatment for these patients with very limited metastatic disease.

Project
EU-fix, Rapid protyping of new adaptive workflows for the MRILinac

Three most recent publications

Werensteijn-Honingh AM, Jürgenliemk-Schulz IM, Gadellaa-Van Hooijdonk CG, Sikkes GG, Vissers NGPM, Winkel D, Eppinga WSC, Intven M, Raaymakers BW, Kroon PS. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases. Radiother Oncol 2021;154:110-7. https://doi.org/10.1016/j.radonc.2020.09.021
Winkel D, Werensteijn-Honingh AM, Eppinga WSC, Intven MPW, Hes J, Snoeren LMW, Visser SA, Bol GH, Raaymakers BW, Jürgenliemk-Schulz IM, Kroon PS. Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac. Radiother Oncol 2021;154:243-8. https://doi.org/10.1016/j.radonc.2020.09.020
Winkel D, Bol GH, Werensteijn-Honingh AM, Intven MPW, Eppinga WSC, Hes J, Snoeren LMW, Sikkes GG, Gadellaa-van Hooijdonk CGM, Bas W Raaymakers BW, Jürgenliemk-Schulz IM, Kroon PS. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment. Radiother Oncol 2020;146:118-25. https://doi.org/10.1016/j.radonc.2020.02.011

Contact
Email: a.m.honingh@umcutrecht.nl
Pubmed ORCID